Literature DB >> 24787053

Ocular cytokinome is linked to clinical characteristics in ocular toxoplasmosis.

Alejandra de-la-Torre1, Alexander W Pfaff2, Michael E Grigg3, Odile Villard2, Ermanno Candolfi2, Jorge E Gomez-Marin4.   

Abstract

PURPOSE: To determine the cytokine levels in aqueous humor (AH) of Colombian patients with active ocular toxoplasmosis (OT), and to correlate them with their clinical characteristics.
METHODS: 27 Cytokines/chemokines were assayed in 15 AH samples (nine patients with diagnosis of OT biologically-confirmed and six controls that underwent cataract surgery). Correlations were assessed between cytokine/chemokine levels, type of inflammatory response (Th1, Th2, Th17, Treg), and clinical characteristics.
RESULTS: Th2 predominant response was related to more severe clinical features. The presence of VEGF and IL-5 was related to higher number of recurrences. Growth factors (VEGF, FGF, PDGF-β), were related to higher number of lesions. Patients infected by type-I/III strains had a particular intraocular cytokine-pattern.
CONCLUSIONS: Th2 response was related to more severe clinical characteristics in patients infected by Type I/III strains. IL-5 and VEGF were associated with recurrences. We correlate for the first time, specific cytokine-patterns with clinical characteristics and with the infecting Toxoplasma strain.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Colombia; Intraocular cytokines; Th2; Toxoplasma gondii; Uveitis

Mesh:

Substances:

Year:  2014        PMID: 24787053      PMCID: PMC4889015          DOI: 10.1016/j.cyto.2014.03.005

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  41 in total

1.  Evaluation of the usefulness of six commercial agglutination assays for serologic diagnosis of toxoplasmosis.

Authors:  Odile Villard; Bernard Cimon; Jacqueline Franck; Hélène Fricker-Hidalgo; Nadine Godineau; Sandrine Houze; Luc Paris; Hervé Pelloux; Isabelle Villena; Ermanno Candolfi
Journal:  Diagn Microbiol Infect Dis       Date:  2012-04-26       Impact factor: 2.803

Review 2.  Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype?

Authors:  Kenneth G-J Ooi; Grazyna Galatowicz; Virginia L Calder; Susan L Lightman
Journal:  Clin Med Res       Date:  2006-12

Review 3.  Th1 and Th17 cells: adversaries and collaborators.

Authors:  Jesse M Damsker; Anna M Hansen; Rachel R Caspi
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

4.  Cytokine analysis of aqueous humor in HIV patients with cytomegalovirus retinitis.

Authors:  Jayant Venkatramani Iyer; John Connolly; Rupesh Agrawal; Tun Kuan Yeo; Bernett Lee; Bijin Au; Stephen C Teoh
Journal:  Cytokine       Date:  2013-09-03       Impact factor: 3.861

5.  Direct genotyping of animal and human isolates of Toxoplasma gondii from Colombia (South America).

Authors:  Carolina Gallego; Carlos Saavedra-Matiz; Jorge Enrique Gómez-Marín
Journal:  Acta Trop       Date:  2005-11-28       Impact factor: 3.112

6.  Frequency and factors associated with recurrences of ocular toxoplasmosis in a referral centre in Colombia.

Authors:  A de-la-Torre; A C Rios-Cadavid; C M Cardozo-García; J E Gomez-Marín
Journal:  Br J Ophthalmol       Date:  2009-05-07       Impact factor: 4.638

7.  International Uveitis Study Group (IUSG): clinical classification of uveitis.

Authors:  Jean Deschenes; Philip I Murray; Narsing A Rao; Robert B Nussenblatt
Journal:  Ocul Immunol Inflamm       Date:  2008 Jan-Feb       Impact factor: 3.070

8.  Microglia expressing interleukin-13 undergo cell death and contribute to neuronal survival in vivo.

Authors:  Won Ho Shin; Da-Yong Lee; Keun Woo Park; Seung Up Kim; Myung-Soon Yang; Eun-Hye Joe; Byung Kwan Jin
Journal:  Glia       Date:  2004-04-15       Impact factor: 7.452

9.  Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis.

Authors:  Takeru Yoshimura; Koh-Hei Sonoda; Nobuyuki Ohguro; Yoshiyuki Ohsugi; Tatsuro Ishibashi; Daniel J Cua; Takashi Kobayashi; Hiroki Yoshida; Akihiko Yoshimura
Journal:  Rheumatology (Oxford)       Date:  2009-01-22       Impact factor: 7.580

10.  Severe South American ocular toxoplasmosis is associated with decreased Ifn-γ/Il-17a and increased Il-6/Il-13 intraocular levels.

Authors:  Alejandra de-la-Torre; Arnaud Sauer; Alexander W Pfaff; Tristan Bourcier; Julie Brunet; Claude Speeg-Schatz; Laurent Ballonzoli; Odile Villard; Daniel Ajzenberg; Natarajan Sundar; Michael E Grigg; Jorge E Gomez-Marin; Ermanno Candolfi
Journal:  PLoS Negl Trop Dis       Date:  2013-11-21
View more
  17 in total

1.  Genetic Polymorphisms in Cytokine Genes in Colombian Patients with Ocular Toxoplasmosis.

Authors:  C A Naranjo-Galvis; A de-la-Torre; L E Mantilla-Muriel; L Beltrán-Angarita; X Elcoroaristizabal-Martín; R McLeod; N Alliey-Rodriguez; I J Begeman; C López de Mesa; J E Gómez-Marín; J C Sepúlveda-Arias
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

Review 2.  Strain hypothesis of Toxoplasma gondii infection on the outcome of human diseases.

Authors:  J Xiao; R H Yolken
Journal:  Acta Physiol (Oxf)       Date:  2015-01-28       Impact factor: 6.311

Review 3.  An overview of seventy years of research (1944-2014) on toxoplasmosis in Colombia, South America.

Authors:  William Alberto Cañón-Franco; Natalia López-Orozco; Jorge Enrique Gómez-Marín; Jitender P Dubey
Journal:  Parasit Vectors       Date:  2014-09-04       Impact factor: 3.876

4.  Cerebral and ocular toxoplasmosis related with IFN-γ, TNF-α, and IL-10 levels.

Authors:  Cristina S Meira; Vera L Pereira-Chioccola; José E Vidal; Cinara C Brandão de Mattos; Gabriela Motoie; Thais A Costa-Silva; Ricardo Gava; Fábio B Frederico; Luiz C de Mattos
Journal:  Front Microbiol       Date:  2014-10-13       Impact factor: 5.640

Review 5.  Innate recognition of Toxoplasma gondii in humans involves a mechanism distinct from that utilized by rodents.

Authors:  Alan Sher; Kevin Tosh; Dragana Jankovic
Journal:  Cell Mol Immunol       Date:  2016-05-09       Impact factor: 11.530

6.  VEGF Production Is Regulated by the AKT/ERK1/2 Signaling Pathway and Controls the Proliferation of Toxoplasma gondii in ARPE-19 Cells.

Authors:  Juan-Hua Quan; Hassan Ahmed Hassan Ahmed Ismail; Guang-Ho Cha; Young-Joon Jo; Fei Fei Gao; In-Wook Choi; Jia-Qi Chu; Jae-Min Yuk; Young-Ha Lee
Journal:  Front Cell Infect Microbiol       Date:  2020-04-28       Impact factor: 5.293

7.  Different composition of intraocular immune mediators in Posner-Schlossman-Syndrome and Fuchs' Uveitis.

Authors:  Dominika Pohlmann; Stephan Schlickeiser; Sylvia Metzner; Matthias Lenglinger; Sibylle Winterhalter; Uwe Pleyer
Journal:  PLoS One       Date:  2018-06-26       Impact factor: 3.240

8.  Immune Mediator Profile in Aqueous Humor Differs in Patients with Primary Acquired Ocular Toxoplasmosis and Recurrent Acute Ocular Toxoplasmosis.

Authors:  Claudia Thieme; Stephan Schlickeiser; Sylvia Metzner; Claudia Dames; Uwe Pleyer
Journal:  Mediators Inflamm       Date:  2019-02-17       Impact factor: 4.711

9.  A Perspective on Thiazolidinone Scaffold Development as a New Therapeutic Strategy for Toxoplasmosis.

Authors:  Cristian Rocha-Roa; Diego Molina; Néstor Cardona
Journal:  Front Cell Infect Microbiol       Date:  2018-10-16       Impact factor: 5.293

10.  Coinfections and differential diagnosis in immunocompetent patients with uveitis of infectious origin.

Authors:  Alejandra de-la-Torre; Juanita Valdés-Camacho; Clara López de Mesa; Andrés Uauy-Nazal; Juan David Zuluaga; Lina María Ramírez-Páez; Felipe Durán; Elizabeth Torres-Morales; Jessica Triviño; Mateo Murillo; Alba Cristina Peñaranda; Juan Carlos Sepúlveda-Arias; Jorge Enrique Gómez-Marín
Journal:  BMC Infect Dis       Date:  2019-01-25       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.